Details for Patent: 11,786,455
✉ Email this page to a colleague
Which drugs does patent 11,786,455 protect, and when does it expire?
Patent 11,786,455 protects ZTLIDO and is included in one NDA.
This patent has fourteen patent family members in eight countries.
Drugs Protected by US Patent 11,786,455
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 11,786,455 | ⤷ Subscribe | Y | METHOD FOR RELIEVING THE PAIN ASSOCIATED WITH POST-HERPETIC NEURALGIA | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,786,455
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | 112013028802 | ⤷ Subscribe | |||
Brazil | 122021017591 | ⤷ Subscribe | |||
Canada | 2835595 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |